SalvGlandDx分子分析提升涎腺细胞病理恶性风险估计与诊断
该多中心探索性研究对106例涎腺细针穿刺细胞学标本行SalvGlandDx panel分子分析,基于切除标本诊断计算各分子改变的恶性风险(ROM)。63例技术合格病例中76%检出分子改变,94%的分子改变病例结合分子结果后可归入不同Milan类别,仅2%的不确定恶性潜能肿瘤仍维持原分类。结论提示分子分析有助于提高ROM估计并将不确定恶性潜能病例归入明确良性或恶性类别。
要点
- 涎腺FNA细胞学标本可行SalvGlandDx分子分析,63例合格病例中76%检出分子改变。
- 结合分子改变及其ROM后,94%的分子改变病例可重新归入不同Milan类别。
- 分子分析有助于将不确定恶性潜能病例归入明确良性或恶性类别。
核心结论
- 涎腺FNA细胞学标本的分子分析有助于涎腺肿瘤分类,可改善ROM估计并将既往未知恶性潜能病例归入明确良性或恶性类别。
研究设计与样本
- 多中心探索性研究,对106例涎腺细针穿刺细胞学标本行SalvGlandDx panel分子分析。
- 基于切除标本诊断计算每个检出分子改变的恶性风险(ROM)。
- 结合分子改变、其相关ROM、临床与细胞学特征及现有文献评估Milan类别。
主要发现
- 63例技术合格病例中76%检出分子改变。
- 分子改变病例中94%在结合分子结果后可归入不同Milan类别。
- 检出分子改变的不确定恶性潜能涎腺肿瘤中仅2%仍维持不确定恶性潜能分类。
关键数值与推荐
- Milan系统为涎腺细胞病理提供估计ROM,但其中两个类别病变诊断仍不明确。
- 共106例细胞学标本接受SalvGlandDx panel分子分析,63例为技术合格病例。
临床怎么用
- 对涎腺FNA细胞学标本可考虑SalvGlandDx分子分析以辅助Milan分类和ROM估计。
- 分子结果结合临床与细胞学特征有助于优化手术及影像规划等患者管理。
局限性
- 本研究为探索性多中心研究,技术合格病例为63例。
- 原文摘要未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diagnosis of salivary gland neoplasms is challenging, especially on cytological specimens acquired by fine-needle aspiration. The recently implemented standardized Milan system for reporting salivary gland cytopathology provides an estimated risk of malignancy (ROM); yet, for two of the categories, the diagnosis of the lesion remains unclear. However, a precise diagnosis is desirable for optimal patient management, including planning of surgery and imaging procedures. METHODS: Cytological specimens (n = 106) were subjected to molecular analysis using the SalvGlandDx panel. The risk of malignancy was calculated for each detected alteration based on the diagnosis of the resection specimen. By taking into account the molecular alterations, their associated ROM, the clinical and cytological features, and the current literature, the Milan category was evaluated. RESULTS: Of n = 63 technically valid cases, 76% revealed a molecular alteration. A total of 94% of these molecularly altered cases could be assigned to a different Milan category when additionally taking molecular results into account. In only 2% of the salivary gland neoplasms of uncertain malignant potential, in which a molecular alteration was detected, the classification remained salivary gland neoplasms of uncertain malignant potential. CONCLUSION: Molecular analysis of cytological specimens provides a benefit in classifying salivary gland neoplasms on fine-needle aspiration. It can improve the ROM estimation and thus help to assign cases of formerly unknown malignant potential to clearly benign or malignant categories.
引用
- Freiberger SN, Ikenberg K, van Egmond D, et al. Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study. Cancer Cytopathol. 2024. PMID: 38563876. doi:10.1002/cncy.22814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。